Akynzeo
Payments companies reported to CMS as associated with Akynzeo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Akynzeo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Akynzeo
These are the largest totals companies reported as associated with Akynzeo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Faith Mutale | Philadelphia, PA | Nurse Practitioner | $4,071.44 |
| Nashat Gabrail | Canton, OH | $178.30 | |
| Pedro Gil Solivan Ortiz | Rio Piedras, PR | $147.57 | |
| Erin Fleener | Bryan, TX | Hematology & Oncology | $87.62 |
| Darlene Paguio | Huntington Beach, CA | Physician Assistant | $85.96 |
| Sivamurthy Kyathari | Green Valley, AZ | Hematology & Oncology | $59.37 |
| Eddiemar Ortiz Cruz | San Juan, PR | Hematology & Oncology | $50.00 |
| Natalie Floyd | Hawkinsville, GA | Nurse Practitioner | $49.14 |
| Karina Arocho-Gonzalez | Hato Rey, PR | Hematology & Oncology | $48.34 |
| Jose Abreu Arbelo | San Juan, PR | Hematology & Oncology | $48.34 |
Prescribed Akynzeo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.